Cigna Expands Coverage for AI-Powered Cardiovascular Imaging

The Cigna Group has recently approved coverage for Cleerly’s AI-powered cardiovascular imaging technology, specifically the Cleerly LABS Advanced Plaque Analysis. This decision positions Cigna alongside other major payors like UnitedHealthcare and EviCore, enhancing access to advanced diagnostic tools for over 61 million Americans. The integration of this technology is part of a broader trend toward value-based care, aiming to improve patient outcomes while managing healthcare costs effectively.

The Globe and Mail (Toronto)Built to Close Care Gaps, Pluto Health Partners With More PayersReducing Hypertension Through Self-Measured Blood Pressure Monitoring Programs

Cleerly’s platform utilizes artificial intelligence to accurately identify and measure plaque buildup in coronary arteries, offering a significant improvement over traditional imaging methods. This advancement is particularly relevant as cardiovascular diseases represent some of the highest medical expenditures. By facilitating earlier detection, Cigna anticipates a reduction in hospitalization and emergency care costs, aligning with its goal of integrating innovative technologies into its healthcare offerings.

The Globe and Mail (Toronto)

Cigna's move reflects a competitive landscape where other insurers are also adapting to value-based care models. UnitedHealth Group, for instance, reported a 5.8% year-over-year growth in its Optum division, which focuses on reducing hospital admissions and enhancing chronic condition management. Elevance Health is transitioning from traditional insurance to a more integrated healthcare solutions provider, while Humana has seen a 9% increase in total adjusted revenues in the first half of 2025, emphasizing its commitment to improving the overall healthcare experience.

The Globe and Mail (Toronto)Built to Close Care Gaps, Pluto Health Partners With More PayersReducing Hypertension Through Self-Measured Blood Pressure Monitoring Programs

Cigna's decision to cover Cleerly’s technology underscores its commitment to advancing digital healthcare and improving patient outcomes. The company aims to solidify its competitive edge in the industry while enhancing customer loyalty through innovative solutions. This strategic initiative aligns with the growing emphasis on preventive care and population health management.

The Globe and Mail (Toronto)

While the adoption of AI in healthcare is generally viewed positively, some critics express concerns regarding the reliance on technology for critical health assessments. They argue that while AI can enhance diagnostic accuracy, it should not replace the essential human element in patient care. Additionally, there are apprehensions about data privacy and the implications of widespread AI integration in healthcare settings.

The Globe and Mail (Toronto)

As Cigna implements this new coverage, it will be essential to monitor the outcomes associated with the use of AI-powered diagnostics in cardiovascular health. The upcoming launch of the new CPT I code in January 2026 will further facilitate the integration of these technologies into standard care practices. The ongoing evolution of healthcare delivery models will likely continue to shape the landscape of patient care and insurance coverage in the coming years.

The Globe and Mail (Toronto)